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he  normal  iron  content  of  the  body  is  3--4  g.  It  exists
n  hemoglobin,  in  iron-containing  proteins  different  to
emoglobin,  in  iron  bound  to  transferrin  in  plasma,  and  in
he  form  of  ferritin  and  hemosiderin.  There  is  approximately
 g  of  storage  iron,  mostly  in  liver,  spleen,  and  bone  marrow.1
Iron  is  lost  in  sweat,  shed  skin  cells,  and  gastrointesti-
al  loss  at  a  rate  of  approximately  1  mg/day.  Menstruating
omen  lose  an  additional  0.5  mg/day  to  1.0  mg/day  of  iron.
Iron  overload  occurs  when  there  is  increased  absorption
f  iron  from  a  normal  diet,  or  when  the  subject  has  received
arge  doses  of  parenteral  iron  from  multiple  red  cell  trans-
usions  or  multiple  infusions  of  intravenous  iron.
tiology
here  is  no  mechanism  for  iron  excretion  once  it  has  been
bsorbed  into  the  body  therefore  iron  overload  is  found  in
he  following  conditions.2--4
ncreased  absorption  from  a  normal  diet
een  in  the  various  forms  of  hereditary  hemochromatosis,
n  patients  with  thalassemia  with  ineffective  erythropoiesis,
nd  in  patients  with  congenital  or  acquired  clonal  siderob-
astic  anemia.  In  all  of  these  conditions,  there  is  relative∗ Corresponding author at: Servicio de Hematología del Depar-
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idin.
ereditary  hemochromatosis
n  patients  with  homozygous  hereditary  hemochromatosis
HH),  the  absorption  of  iron  is  not  regulated  by  serum
erritin.5 These  patients  may  absorb  2--4  mg  of  iron.3
ultiple  infusions  of  iron-containing  agents
ron  overload  can  occur  secondary  to  multiple  intravenous
nfusions  of  the  following  iron-containing  products:
 Red  cell  transfusions.  Each  red  blood  cells  unit  contains
200  mg  of  elemental  iron.  Patients  who  have  received
more  than  10  red  cell  transfusions  are  at  risk  of  iron  over-
load.
 Intravenous  iron.  Patients  with  renal  failure  and  cancer
patients  who  have  been  treated  with  multiple  courses  of
intravenous  iron  in  addition  to  erythropoiesis-stimulating
agents  may  develop  iron  overload.
 Intravenous  hemin/hematin.  Patients  with  porphyria  are
at  risk  of  developing  iron  overload  because  of  treatment
with  intravenous  hematin/hemin.
iver  diseasecute  and  chronic  liver  disorders  are  associated  with  inﬂam-
ation  and  an  increase  in  ferritin  levels,  since  ferritin  is  an
cute  phase  reactant.
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•Iron  overload  
•  In  alcoholic  liver  disease,  increased  levels  of  iron  can  be
found,  although  not  to  the  extent  seen  in  patients  with
hereditary  hemochromatosis.
• In  patients  with  porphyria  cutanea  tarda  and  HCV  infec-
tion,  iron  plays  a  role  in  the  development  of  symptoms.
•  It  may  not  be  possible  distinguish  some  liver  diseases  from
the  liver  damage  seen  in  hereditary  hemochromatosis.
Work up
Iron  overload  is  demonstrated  by  serum  ferritin,  transferrin
saturation,  Magnetic  Resonance  Image  techniques  (MRI)  and
liver  biopsy.6 All  patients  suspected  of  having  iron  overload,
should  also  be  studied  for  HH.
Iron  overload  is  deﬁned  by  the  ﬁnding  of  an  increased
transferrin  saturation  with  an  increased  plasma  ferritin
concentration  when  the  patient  is  free  of  inﬂammation.
Iron  overload  is  present  when  transferrin  saturation  exceeds
45  percent  and  is  associated  with  tissue  damage  when  it
exceeds  70--75  percent.
The  ﬁnding  of  a  serum  ferritin  level  greater  than
200--300  ng/mL  in  men  or  150--200  ng/mL  in  women  is  sug-
gestive  of  iron  overload.  Ferritin  is  an  acute  phase  reactant
and  serum  levels  may  ﬂuctuate  over  time,  a  normal  level  of
C-reactive  protein  suggests  that  an  elevated  ferritin  is  not
due  to  inﬂammation  or  infection.  It  is  a  poor  predictor  of
Liver  Iron  Concentration  (LIC)  for  the  individual  patient,  and
its  accuracy  depends  on  the  underlying  liver  disease.7--11 A
high  ferritin  level  alone  is  not  sufﬁcient  for  making  the  diag-
nosis  of  iron  overload.  It  is  recommended  that  both  serum
ferritin  and  transferrin  saturation  must  be  studied  in  all
patients.12
Noninvasive  imaging  studies,  such  as  CT  scanning  and
T2  and  R2  (FerriScan)  measurements  by  MRI,  have  become
increasingly  accurate  for  determining  hepatic  and  cardiac
iron  deposition.6,13--22 A  liver  iron  concentration  (LIC)  esti-
mated  by  MRI  greater  than  7  mg  Fe/g  dry  weight  indicates
the  presence  of  hepatic  iron  overload  and  a  cardiac  T2  by  MRI
greater  than  20  milliseconds  indicates  cardiac  iron  overload.
Parenchymal  iron  loading  can  be  demonstrated  semi-
quantitatively  by  Perls’  Prussian  blue  staining  of  a  liver
biopsy  specimen23,24 and  can  be  directly  analyzed  for  hepatic
iron  content  (HIC).  The  upper  limit  of  normal  is  1.4  mg/g  to
1.8  mg/g  and  with  any  value  greater  than  2.0  mg/g  being
considered  abnormal.25,26
When to suspect iron overload
Iron  overload  is  suspected  in  relatives  of  individuals  with
hereditary  hemochromatosis,  in  those  who  have  received
multiple  red  cell  transfusions  and  those  with  a  known  disor-
der  or  clinical  situation  predisposing  to  iron  overload.
Since  iron  overload  from  any  cause  can  ultimately  lead
to  organ  failure  in  the  heart,  liver,  and  various  endocrine
organs,  presence  of  one  or  more  of  the  following  signs  and
symptoms  should  also  make  the  clinician  suspect  the  pres-
ence  of  iron  overload  with  resulting  organ  damage,
•  Unexplained  abnormalities  in  liver  function,  chronic  liver
disease,  cirrhosis
•241
 Cardiac  enlargement  with  or  without  heart  failure  or
conduction  defects
 Diabetes  mellitus
 Hypogonadism
 Skin  hyperpigmentation
 Unexplained  fatigue
iagnosis
ron  overload  is  diagnosed  by  demonstrating  an  elevated
erum/plasma  ferritin  along  with  an  increased  transferrin
aturation  on  more  than  one  occasion,
 Serum  ferritin  greater  than  200--300  ng/mL  in  men  or
150--200  ng/mL  in  women
 Transferrin  saturation  greater  than  45  percent,  and
 The  following  specialized  tests  document  the  presence
and  magnitude  of  iron  overload
◦  A  liver  iron  concentration  (LIC)  estimated  by  MRI
greater  than  7  mg  Fe/g  dry  and  a  cardiac  T2*  by  MRI
greater  than  20  ms.
◦  Levels  of  hepatic  iron  greater  than  2  mg/g  as
obtained  by  liver  biopsy  are  indicative  of  hepatic  iron
overload.4,27
 All  patients  evaluated  for  iron  overload  should  have  C282Y
and  H63D  mutation  analysis  for  diagnosing  the  presence
(or  absence)  of  HH.
 The  ﬁnding  of  a  C282Y/C282Y  genotype  conﬁrms  the  diag-
nosis  of  HH.
 Heterozygote  genotype  (C282Y/H63D  genotype)  have  a  60
percent  of  an  intermediate  degree  of  iron  loading.
 Patients  with  a  C282Y/wild  type  (wt)  genotype  are  less
risk  of  iron  overload.28
ummary and recommendations
ron  overload  is  seen  in  a  number  of  clinical  settings;  most
ommon  are  multiple  transfusions,  liver  disease,  and  hered-
tary  hemochromatosis  (HH).
One  or  more  of  the  following  signs  and  symptoms  should
ake  the  clinician  suspect  the  presence  of  organ  damage
econdary  to  iron  overload
 Unexplained  abnormalities  in  liver  function,  chronic  liver
disease  or  cirrhosis
 Cardiac  enlargement  with  or  without  heart  failure  or
conduction  defects
 Diabetes  mellitus
 Hypogonadism
 Skin  hyperpigmentation
 Unexplained  fatigue
 Positive  family  history  of  iron  overload
 All  patients  suspected  of  having  iron  overload  should  have
iron  studies  as  well  as  genetic  testing.
 Serum  ferritin  greater  than  200--300  ng/mL  in  men  or
150--200  ng/mL  in  women  and/or  a  transferrin  saturation
greater  than  45  percent  indicates  iron  overload.
 A  choice  among  these  options:
◦  A  liver  iron  concentration  estimated  by  MRI  greater
than  7  mg  Fe/g  dry  weight  indicates  the  presence  of
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hepatic  iron  overload  and  a  cardiac  T2*  over  20  milli-
seconds  indicates  the  presence  of  cardiac  iron  overload
◦  A  liver  biopsy  performed  speciﬁcally  for  the  determi-
nation  of  iron  overload  is  rarely  needed.
 All  patients  being  evaluated  for  iron  overload  should  have
C282Y  and  H63D  mutation  analysis.
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